183 related articles for article (PubMed ID: 8676089)
1. Protection against lethal toxic shock by targeted disruption of the CD28 gene.
Saha B; Harlan DM; Lee KP; June CH; Abe R
J Exp Med; 1996 Jun; 183(6):2675-80. PubMed ID: 8676089
[TBL] [Abstract][Full Text] [Related]
2. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
4. Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock.
Arad G; Levy R; Nasie I; Hillman D; Rotfogel Z; Barash U; Supper E; Shpilka T; Minis A; Kaempfer R
PLoS Biol; 2011 Sep; 9(9):e1001149. PubMed ID: 21931534
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
Feng MH; Cui JC; Nakane A; Hu DL
Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
[TBL] [Abstract][Full Text] [Related]
6. Induction of unresponsiveness and impaired T cell expansion by staphylococcal enterotoxin B in CD28-deficient mice.
Mittrücker HW; Shahinian A; Bouchard D; Kündig TM; Mak TW
J Exp Med; 1996 Jun; 183(6):2481-8. PubMed ID: 8676068
[TBL] [Abstract][Full Text] [Related]
7. Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice.
Dinges MM; Schlievert PM
Infect Immun; 2001 Mar; 69(3):1256-64. PubMed ID: 11179286
[TBL] [Abstract][Full Text] [Related]
8. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
9. V beta specificity of superantigen TSST-1 plus CD28 costimulation without APCs.
Hu WG; Zhu XH
Immunol Invest; 1996; 25(5-6):405-11. PubMed ID: 8915678
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.
Krakauer T; Stiles BG
Clin Diagn Lab Immunol; 1999 Jul; 6(4):594-8. PubMed ID: 10391869
[TBL] [Abstract][Full Text] [Related]
11. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcal enterotoxin B-induced activation and concomitant resistance to cell death in CD28-deficient HLA-DQ8 transgenic mice.
Rajagopalan G; Smart MK; Marietta EV; David CS
Int Immunol; 2002 Jul; 14(7):801-12. PubMed ID: 12096040
[TBL] [Abstract][Full Text] [Related]
13. A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation.
Cullen CM; Blanco LR; Bonventre PF; Choi E
Infect Immun; 1995 Jun; 63(6):2141-6. PubMed ID: 7768593
[TBL] [Abstract][Full Text] [Related]
14. [Neutralizing activity of human immunoglobulin preparation against toxic shock syndrome toxin-1].
Nakae T; Hirayama F; Hashimoto M
Kansenshogaku Zasshi; 2002 Mar; 76(3):195-202. PubMed ID: 11974889
[TBL] [Abstract][Full Text] [Related]
15. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
Schlievert PM; Cahill MP; Hostager BS; Brosnahan AJ; Klingelhutz AJ; Gourronc FA; Bishop GA; Leung DYM
mBio; 2019 Mar; 10(2):. PubMed ID: 30890614
[TBL] [Abstract][Full Text] [Related]
17. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
18. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
Dennig D; O'Reilly RJ
J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
[TBL] [Abstract][Full Text] [Related]
19. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
Micusan VV; Mercier G; Bhatti AR; Reiser RF; Bergdoll MS; Oth D
Immunology; 1986 Jun; 58(2):203-8. PubMed ID: 3486824
[TBL] [Abstract][Full Text] [Related]
20. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
Kum WW; Hung RW; Cameron SB; Chow AW
J Infect Dis; 2002 Feb; 185(4):555-60. PubMed ID: 11865410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
